Pancancer analysis uncovers an immunological role and prognostic value of the m6A reader IGF2BP2 in pancreatic cancer

Introduction: Pancreatic ductal adenocarcinoma (PDAC) is one of the most malignant gastrointestinal tumors worldwide with a dismal prognosis and high relapse rate. PDAC is considered a “cold cancer” for which immunotherapy is not effective. Therefore, to improve the prognosis for PDAC patients, it i...

Full description

Bibliographic Details

Published in:	Molecular and Cellular Probes
Main Authors:	Hui Deng, Hanming Yao, Shurui Zhou, Chong He, Yuzhou Huang, Yunlong Li, Hanwei Chen, Jianchang Shu
Format:	Article
Language:	English
Published:	Elsevier 2024-02-01
Subjects:	IGF2BP2 PD-L1 Tumor immunity Pancreatic cancer Pan-cancer analysis
Online Access:	http://www.sciencedirect.com/science/article/pii/S0890850823000579